Green protalix biotherapeutics inc plx announces quarterly earnings results

Related Stories:

Living

Green

protalix biotherapeutics inc plx announces quarterly earnings results

alphabet inc goog receives consensus price target analysts

scaling flower farm

chanticleer modern gardener garden susan harris

notre dame students walk during mike pencersquos commencement speech

main street capital rating lowered underperform citigroup inc

Green Sun May 21 2017 23:54:33 GMT+0000 (UTC)
WHERE THE PARTY'S AT -- Protalix Biotherapeutics Inc (NYSEMKT:PLX) posted its quarterly earnings results on Wednesday. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.02. The business had revenue of $2.89 mill
salesforce.com, inc. (NYSE:CRM) Chairman Marc Benioff sold 10,000 shares of the stock in a transaction dated Wednesday, May 10th. The stock was sold at an average price of $87.19, for a total transaction of $871,900.00. Following the sale, the chairm
LS Investment Advisors LLC increased its stake in Centene Corp (NYSE:CNC) by 10.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,392 shares of the company